Correction: STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort

• Timothy Price,
• Chiara Cremolini,
• Alfredo Falcone,
• Eric Van Cutsem,
• Julien Taieb,
• Jean-Marc Phelip,
• Jean-Baptiste Bachet,
• Lucjan Wyrwicz,
• Fabienne Portales,
• Ahmet Ozet,
• Irfan Cicin,
• Dan Atlan,
• Martin Becquart,
• Loick Vidot,
• Nadjat Mounedji

Affiliations

Timothy Price

Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia

Chiara Cremolini

Department of Translational Medicine, Division of Medical Oncology, University of Pisa, Pisa, Italy

Alfredo Falcone

Department of Translational Medicine, Division of Medical Oncology, University of Pisa, Pisa, Italy

Eric Van Cutsem

5 Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgium

Julien Taieb

8European Georges Pompidou Hospital, Paris, France

Jean-Marc Phelip

Department of Gastroenterology, Centre Hospitalier Universitaire de Saint-Etienne, Saint-Etienne, Rhône-Alpes, France

Jean-Baptiste Bachet

Department of Hepatogastroenterology, University Hospital Pitié Salpêtrière, Paris, Île-de-France, France

Lucjan Wyrwicz

Aff9 0000 0004 0540 2543grid.418165.fMaria Skłodowska-Curie Memorial Cancer Center, Department of Oncology and Radiotherapy and Biostatistics and Bioinformatics Unit Warsaw Poland

Fabienne Portales

Department of Medical Oncology, Institut régional du Cancer de Montpellier, Montpellier, France

Ahmet Ozet

Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey

Irfan Cicin

Department of Medical Oncology, Trakya University, Edirne, Turkey

Dan Atlan

Global Medical Affairs, Servier Médical, Suresnes, Île-de-France, France

Martin Becquart

Global Medical Affairs, Servier Médical, Suresnes, Île-de-France, France

Loick Vidot

Institut de Recherches Internationales Servier, Suresnes, France

Nadjat Mounedji

Global Medical Affairs, Servier Médical, Suresnes, Île-de-France, France